Form 8-K PEREGRINE PHARMACEUTICAL For: Mar 10
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Peregrine Pharma (PPHM) Reports In-Line Q2 EPS
March 12, 2015 4:01 PM EDTPeregrine Pharma (NASDAQ: PPHM) reported Q2 EPS of ($0.08), in-line with the analyst estimate of ($0.08). Revenue for the quarter came in at $5.68 million versus the consensus estimate of $4.23 million.
For earnings history and earnings-related data on Peregrine Pharma (PPHM) click here.
... More